Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 8, 2014, Pages 830-838

  Huybrechts, Krista F ^a   Gerhard, Tobias ^b,c   Franklin, Jessica M ^a   Levin, Raisa ^a   Crystal, Stephen ^c   Schneeweiss, Sebastian ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c The State University of New Jersey   (United States)

Author keywords

Comparative effectiveness; Confounding; Epidemiologic methods; Instrumental variable; Nursing home; Pharmacoepidemiology; Prescribing preference

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; HYPNOTIC AGENT; PSYCHOTROPIC AGENT;

AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONFOUNDING VARIABLE; DRUG CHOICE; HEALTH CARE QUALITY; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MAJOR CLINICAL STUDY; MORTALITY; NURSING HOME; NURSING HOME PATIENT; PRESCRIPTION; PRIORITY JOURNAL; VALIDITY; CLINICAL PRACTICE; COHORT ANALYSIS; DEMENTIA; EPIDEMIOLOGY; INFORMATION PROCESSING; MEDICAID; MEDICARE; PROCEDURES; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA COLLECTION; DEMENTIA; HUMANS; LOGISTIC MODELS; MEDICAID; MEDICARE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 84904979483     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3611     Document Type: Article

References (37)

1. Walker AM, Stampfer MJ. Observational studies of drug safety. Lancet 1996; 348(9026): 489-489.
2. Petri H, Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med 1991; 10: 577-581.
3. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000; 29(4): 722-729.
4. Hernan M, Robins J. Instruments for causal inference. An epidemiologist's dream? Epidemiology 2006; 17(4): 360-372.
5. Angrist J, Imbens G, Rubin D. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996; 91(434): 444-455.
6. Brookhart M, Rassen J, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf 2010; 19(6): 537-554.
7. Schneeweiss S, Suissa S. Advanced approaches to controlling confounding in pharmacoepidemiologic studies. In Pharmacoepidemiology (5th edn), Strom B, Kimmel S, Hennessy S (eds.). John Wiley & Sons: Chichester, West Sussex, UK; 2012.
8. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994; 272(11): 859-866.
9. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268(11): 1417-1422.
10. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998; 338(21): 1516-1520.
11. Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology 2001; 12(6): 682-689.
12. Sturmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution-a simulation study. Am J Epidemiol 2010; 172(7): 843-854.
13. Gruneir A, Lapane KL. It is time to assess the role of organizational culture in nursing home prescribing patterns. Arch Intern Med 2008; 168(2): 238-239; author reply 239.
14. Hughes CM, Lapane KL. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been? Drugs Aging 2005; 22(4): 339-351.
15. Giron MST, Forsell Y, Bernsten C, Thorslund M, Winblad B, Fastbom J. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16(9): 900-906.
16. Ruths S, Straand J, Nygaard H. Psychotropic drug use in nursing homes-diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57: 523-528.
17. Liperoti R, Mor V, Lapane KL, Pedone C, Gambassi G, Bernabei R. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 2003; 64(9): 1106-1112.
18. Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005; 165(11): 1280-1285.
19. Bronskill SE, Anderson GM, Sykora K, et al. Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact. J Am Geriatr Soc 2004; 52(5): 749-755.
20. Gill SS, Bronskill SE, Normand S-LT, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146(11): 775-786.
21. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. Can Med Assoc J 2007; 176(5): 627-632.
22. Liperoti R, Gambassi G, Lapane KL, et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med 2005; 165(6): 696-701.
23. Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med 2005; 165(22): 2677-2682.
24. Knol W, van Marum R, Jansen P, Souverein P, Schobben A, Egberts A. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 2008; 56: 661-666.
25. Rochon PA, Normand S-L, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168(10): 1090-1096.
26. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353(22): 2335-2341.
27. Gill SS, Rochon PA, Herrmann N, et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ. 2005; 330(7489): 445.
28. Huybrechts K, Gerhard T, Crystal S, et al. Differential risk of death in older nursing home residents prescribed specific antipsychotic medications: population-based cohort study. BMJ 2012; 344: e977.
29. Huybrechts K, Rothman K, Silliman R, Brookhart M, Schneeweiss S. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. Can Med Assoc J 2011; 183(7): E411-E419.
30. Wong G, Mason W. The hierarchical logistic regression model for multilevel analysis. J Am Stat Assoc 1985; 80: 513-524.
31. Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis. Johnn Wiley & Sons, Inc.: Hoboken, New Jersey, 2004.
32. Mahalanobis P. On the generalized distance in statistics. Proced Nat Inst Sci India 1936; 12: 49-55.
33. Terza JV, Basu A, Rathouz PJ. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ May 2008; 27(3): 531-543.
34. Ionescu-Ittu R, Delaney J, Abrahamowicz M. Bias-variance trade-off in pharmacoepdimiological studies using physician-preference-based instrumental variables: a simulation study. Pharmacoepidemiol Drug Saf 2009; 18: 562-571.
35. Pratt N, Roughead EE, Ryan P, Salter A. Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments. Pharmacoepidemiol Drug Saf Jul 2010; 19(7): 699-707.
36. Myers JA, Rassen JA, Gagne JJ, et al. Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol 2011; 174(11): 1213-1222.
37. Brookhart M, Schneeweiss S. Preference-based instrumental variable methods for the estimation of treatment effect: assessing validity and interpreting results. Int J Biostatistics 2007; 3(1): 1-23 (Article 14).